Michael Gladstone

DAWN

Michael Gladstone serves as Director at Day One Biopharmaceuticals, Inc. (DAWN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$11.50M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$11.50M

Companies Traded

DAWN

Active Period

Jun 2022

1 total trades

Most Recent

Buy DAWN

Jun 17, 2022 · $11.50M

Michael Gladstone's Insider Trading at Day One Biopharmaceuticals, Inc. (DAWN)

Buys

1 · $11.50M

Sells

0 · $0.00

Total Shares Bought

766,667

Total Shares Sold

DAWN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 17, 2022↗	Buy	766,667	$15.00	$11.50M	0

Related Insiders

Charles N York II

officer: COO and CFO

DAWNSell · Feb 17, 2026

Jeremy Bender

director, officer: CHIEF EXECUTIVE OFFICER

DAWNSell · Feb 17, 2026

Adam Dubow

Gen Counsel & Secretary

DAWNSell · Feb 17, 2026

Charles N York II

COO and CFO

DAWNSell · Feb 17, 2026

Jeremy Bender

CHIEF EXECUTIVE OFFICER

DAWNSell · Feb 17, 2026

Adam Dubow

officer: Gen Counsel & Secretary

DAWNSell · Feb 17, 2026

Lauren Merendino

Chief Commercial Officer

DAWNSell · Feb 17, 2026

Lauren Merendino

officer: Chief Commercial Officer

DAWNSell · Feb 17, 2026

Explore More Insider Trading Data

DAWN Insider Trading Activity

View all insider trades at Day One Biopharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity